APP and Alzheimer disease: Interestingly, mild inhibition of complex I of the OXPHOS system, e.g., by the small molecule tricyclic pyrone compound CP2, has been suggested as a potential treatment strategy against AD, with positive effects in the APP/PS1 mouse model of AD [73,74].